✦ LIBER ✦

Methotrexate treatment of rheumatic diseases: Can we do better?

✍ Scribed by Joel M. Kremer

Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 51 KB
Volume: 58
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.24032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methotrexate and long-term treatment of

Methotrexate and long-term treatment of rheumatic disease: Comment on the article by Kremer

✍ Prabha Ranganathan; Howard L. McLeod 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 3 views

We Can Do Better—ESRD: State of the Art

We Can Do Better—ESRD: State of the Art and Challenges for the Future

✍ Tom F. Parker III; Theodore I. Steinman 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 57 KB 👁 1 views

Changes in glycosylated hemoglobin after

Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases

✍ Laura R. Rekedal; Elena Massarotti; Rajesh Garg; Radhika Bhatia; Timothy Gleeson 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Do we still need distal protection in th

Do we still need distal protection in the treatment of SVG disease?

✍ Lowell F. Satler 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB

“What shall we do with the inebriate?” a

“What shall we do with the inebriate?” asylum treatment and the disease concept of alcoholism in the late nineteenth century

✍ Edward M. Brown 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 968 KB

During the late nineteenth century a number of physicians, sometimes called inebriety specialists, combined a narrowly physicalistic disease concept of alcoholism with a high regard for the curative power of asylum treatment to advocate the development of specialized asylums for the treatment of alc